Seriously, the Reuters piece might be a tad optimistic wrt market size for the reasons cited by 'ciotera' in #msg-130723194. On the other hand, the article echoes the points I made in #msg-130718964, particularly with respect to combination therapy.
That NASH will continue to be active sector for M&A is not in dispute.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.